Nautilus Biotechnology, Inc. (NAUT) Tops Q1 EPS by 5c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q1 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Tradr 2X Long SpaceX Daily ETF (SPCM) call put ratio 6.8 calls to 1 put with a focus on July 28 calls as share price down 20.6%
• Active options: TSLA NVDA AMZN GOOGL AAPL SPCX MSFT NFLX INTC